The Biopharmaceutical CMO And CRO Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Biopharmaceutical CMO And CRO Market?
The market size of the biopharmaceutical CMO and CRO has experienced significant growth in recent years. It is expected to increase from $33.33 billion in 2024 to $35.6 billion in 2025, with a compound annual growth rate (CAGR) of 6.8%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Biopharmaceutical CMO And CRO Industry?
The Biopharmaceutical CMO And CRO Global Market is projected to reach $45.89 billion by 2029, growing at a compound annual growth rate of 6.6%.
Download Your Free Sample of the 2025 Biopharmaceutical CMO And CRO Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Biopharmaceutical CMO And CRO Market?
The key drivers in the biopharmaceutical cmo and cro market are:
• Rising outsourcing of drug development and manufacturing
• Expanding therapeutic areas and drug pipelines
• Increasing focus on personalized medicine
• Higher investments in biotechnology startups
Global Market Segmentation: Identifying Major Biopharmaceutical CMO And CRO Industry Segments
The biopharmaceutical cmo and cromarket covered in this report is segmented –
1) By Product: Biologics, Biosimilars
2) By Service Type: Contract Manufacturing, Contract Research
3) By Source: Mammalian, Non-Mammalian
Pre-order the 2025 Biopharmaceutical CMO And CRO Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Biopharmaceutical CMO And CRO Market?
The key trends in the biopharmaceutical cmo and cro market are:
• Future trends include the rise of automated and high-throughput technologies in biopharmaceutical processes.
• The use of advanced analytics and artificial intelligence (AI) in drug development is becoming increasingly prevalent.
• There is growing demand for cell and gene therapies in the market.
• The integration of digital technologies in clinical trials is increasingly shaping the future of this market.
Who Are the Top Competitors & Leading Players in the Biopharmaceutical CMO And CRO Market?
Major companies in the biopharmaceutical cmo and cro market are:
• Thermo Fisher Scientific Inc.
• Boehringer Ingelheim International GmbH
• Eurofins Scientific SE
• Lonza Group AG
• Syneos Health Inc.
• Catalent Inc.
• Charles River Laboratories International Inc.
• Parexel International (MA) Corporation
• Samsung Biologics Co. Ltd.
• CELLTRION INC.
• Medpace Holdings Inc.
• Fujifilm Diosynth Biotechnologies UK Limited
• Almac Group
• Pharmaron Beijing Co. Ltd.
• Worldwide Clinical Trials
• KBI Biopharma
• Inotiv Inc.
• Caidya
• Rentschler Biopharma SE
• Celerion Inc.
• TFS HEALTHCARE LIMITED
Regional Dominance: Which Area Leads the Global Biopharmaceutical CMO And CRO Market?
North America was the largest region in the biopharmaceutical CMO and CRO market in 2024
